期刊文献+

肝细胞癌手术切缘对患者术后复发与生存的影响 被引量:16

Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma
原文传递
导出
摘要 目的比较不同的手术切缘对肝癌患者术后复发及生存的影响,为肝癌患者手术中选择合理切缘提供参考。方法将152例初治的可手术切除肝癌患者随机分为两组,分别按以下标准手术:74例宽切缘组患者按门静脉血流方向远端距肿瘤边缘2cm,近端距肿瘤边缘1cm完整切除;78例窄切缘组患者切除范围距离肿瘤<1cm,切缘无癌残留。应用KaplanMeier法进行生存分析,用Logrank检验分别比较两组的无瘤生存期和总生存期。结果宽切缘组患者平均无瘤生存期为35.5个月,平均总生存期为42.0个月;窄切缘组患者平均无瘤生存期为28.8个月,平均总生存期为37.5个月,两组无瘤生存期(t=6.01,P=0.0142)和总生存期(t=6.23,P=0.0125)比较,差异均有统计学意义。结论按门静脉血流方向远端距肿瘤2cm,近端距肿瘤1cm切除为标准的手术范围可较合理地延长肝癌患者术后无瘤生存期和总生存期。 Objective To compare the effect of different resection margin in hepatectomy on recurrence and survival of patients with hepatocellular carcinoma (HCC) , and to determine an appropriate resection margin of hepatectomy for HCC patients. Methods 152 untreated HCC patients were randomly divided into two groups based on the distal and proximal resection margin according to direction of the portal vein flow, Seventy-four patients in the wide-margin group had a distal resection margin of 2 cm and a proximal of 1 cm away from the edge of the primary tumor, while 78 patients in the narrow-margin group had a resection margin of 〈 1 cm away from the edge of the primary tumor provided that the margin was proven to be histologically free of cancer cells. The distal and proximal margins were defined. The data were analyzed and compared using Kaplan-Meier survival analysis and Log rank test. Results The mean overall survival time of patients in wide-margin group and narrow-margin group were 42. 0 months and 37. 5 months, respectively. The mean tumor-free survival time of these two groups of patients were 35.5 months and 28.8 months, respectively. Patients in wide-margin group had significantly longer overall survival (t=6.23, P = 0.0125) and tumor-free survival (t = 6.01, P = O. 0142) than patients in the narrow-margin group. Conclusion In hepatectomy for hepatocellular cell carcinoma patients, wide distal resection margin of 2 cm and a proximal of I cm away from the edge of the primary tumors according to direction of the portal vein flow may reasonably improve the overall and tumor-free survival.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2006年第1期47-49,共3页 Chinese Journal of Oncology
关键词 肝细胞癌 外科学 肝切除术 肿瘤复发 生存 Hepatocellular carcinoma/surgery Hepateetomy Neoplasm recurrence Survival value
  • 相关文献

参考文献9

  • 1李升平,张昌卿,冯凯涛,吴秋良,石明,陈敏山,李锦清.肝癌亚临床转移灶及临床病理学意义的研究[J].中国肿瘤临床,2002,29(2):77-81. 被引量:24
  • 2Shi M,Zhang CQ,Zhang YQ,et al.Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin.World J Surg,2004,28:376-381.
  • 3石明,张昌卿,冯凯涛,张亚奇,陈敏山,郭荣平,林小军,李锦清.肝细胞癌周围微小转移分布的研究[J].中华肿瘤杂志,2002,24(3):257-260. 被引量:35
  • 4马曾辰,黄力文,汤钊猷,周信达,林芷英,钦伦秀,叶青海,孙惠川,任正刚,夏景林.原发性肝癌的三级根治切除标准[J].中华肿瘤杂志,2004,26(1):33-35. 被引量:26
  • 5Chau GY,Lui WY,Tsay SH,et al.Prognostic significance of surgical margin in hepatocellular carcinoma resection:an analysis of 165 Childs' A patients.J Surg Oncol,1997,66:122-126.
  • 6Poon RT,Fan ST,Ng IO,et al.Significance of resection margin in hepatectomy for hepatocellular carcinoma:a critical reappraisal.Ann Surg,2000,231:544-551.
  • 7Yamamoto J,Kosuge T,Takayama T,et al.Recurrence of hepatocellular carcinoma after surgery.Br J Surg,1996,83:1219-1222.
  • 8Schlitt HJ,Neipp M,Weimann A,et al.Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.J Clin Oncol,1999,17:324-331.
  • 9Toyosaka A,Okamoto E,Mitsunobu M,et al.Intrahepatic metastases in hepatocellular carcinoma:evidence for spread via the portal vein as an efferent vessel.Am J Gastroenterol,1996,91:1610-1615.

二级参考文献13

  • 1李锦清,张亚奇,张伟章,元云飞陈敏山,郭荣平,林小军,李国辉.栓塞化疗在肝癌切除术后的价值[J].中华肿瘤杂志,1994,16(5):387-389. 被引量:51
  • 2Foster JH. Computing operative risk. Surgery. 1984. 95:631.
  • 3Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coil Sttrg, 2000,191:381-388.
  • 4Yamanaka N, Okamoto E, Toyosaka A, et al. Criteria of curability in the resection therapy for hepatocellular carcinoma. Nippon Gan Chiryo Gakkai Shi, 1989,24 : 1592-1599.
  • 5Harada T, Kodama S, Matsuo K, et al. Surgical management of large hepatocellular carcinoma: criteria for curative hepatectomy. Int Surg,1993. 78:284-287.
  • 6Kosuge T, Makuuchi M, Takayama T, et al. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepato Gastroenterology, 1993, 40:328-332.
  • 7Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellularcar cinoma after surgery. Br J Surg, 1996,83 : 1219-1222.
  • 8Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology,1994, 106:1618-1624.
  • 9马曾辰.肝癌的手术切除治疗[A].马曾辰吴志全 主编.实用肝胆肿瘤外科学[C].上海:复旦大学出版社,上海医科大学出版社,2001.129-130.
  • 10Jin-qing Li,Ya-qi Zhang,Wei-zhang Zhang,Yun-fei Yuan,Guo-hui Li. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy[J] 1995,Journal of Cancer Research and Clinical Oncology(6):364~366

共引文献79

同被引文献165

引证文献16

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部